MPM BioImpact LLC

13F Filings History

Latest 13F report: Q4 2024 - Feb 14, 2025
Value $: $704M
Signature - Title: Christopher Wolf - Chief Financial Officer
Location: Boston, MA
Summary: This page shows a list of all the recent 13F filings made by MPM BioImpact LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. MPM BioImpact LLC reported 47 stock holdings with total value $704M as of Q4 2024. Top holdings included CGEM, CRNX, EWTX, INSM, and NTRA.

Holdings Value

Quarter	Holdings	Value $	Bought	Sold	Net	Top Holdings	Form Type	Date Filed
Q4 2024	47	$704M	+$199M	-$70.5M	+$129M	CGEM, CRNX, EWTX, INSM, NTRA	13F-HR	2/14/2025, 04:20 PM
Q3 2024	43	$667M	+$122M	-$114M	+$8.21M	CGEM, INSM, OLMA, RNA, CRNX	13F-HR	11/12/2024, 07:40 PM
Q2 2024	44	$644M	+$158M	-$64.2M	+$93.8M	CGEM, INSM, OLMA, ITOS, CRNX	13F-HR	8/14/2024, 11:32 AM
Q1 2024	38	$622M	+$161M	-$77.7M	+$83.7M	CGEM, GERN, IOVA, ZNTL, ITOS	13F-HR	5/15/2024, 04:22 PM
Q4 2023	32	$427M	+$25.4M	-$32.5M	-$7.07M	CGEM, IOVA, OLMA, GERN, ITOS	13F-HR	2/13/2024, 04:06 PM
Q3 2023	32	$375M	+$58.6M	-$121M	-$62.5M	CGEM, OLMA, GERN, RPTX, ITOS	13F-HR	11/14/2023, 04:38 PM
Q2 2023	34	$497M	+$138M	-$67.7M	+$70.4M	CGEM, ISEE, KDNY, GERN, RETA	13F-HR	8/14/2023, 11:19 AM
Q1 2023	31	$385M	+$43.1M	-$29.2M	+$13.9M	CGEM, PRVB, ISEE, ITOS, INBX	13F-HR	5/12/2023, 01:02 PM
Q4 2022	33	$385M	+$49.5M	-$61M	-$11.4M	CGEM, ITOS, INBX, RPTX, ISEE	13F-HR	2/14/2023, 12:41 PM
Q3 2022	38	$422M	+$74.3M	-$14.9M	+$59.4M	CGEM, ITOS, INBX, VERV, NTLA	13F-HR	11/14/2022, 10:22 AM
Q2 2022	37	$357M	+$41.2M	-$22.1M	+$19.1M	CGEM, ITOS, RPTX, MRUS, NTLA	13F-HR	8/11/2022, 05:27 PM
Q1 2022	37	$373M	+$23.5M	-$38.7M	-$15.2M	CGEM, ITOS, MRUS, RPTX, HARP	13F-HR	5/13/2022, 12:05 PM
Q4 2021	33	$549M	+$39.1M	-$58.4M	-$19.3M	CGEM, ITOS, RPTX, MEIP, MRUS	13F-HR	2/11/2022, 04:37 PM
Q3 2021	33	$645M	+$155M	-$13.2M	+$142M	CGEM, ITOS, RPTX, HOWL, TCRR	13F-HR	11/12/2021, 06:19 PM
Q2 2021	14	$609M	+$41.6M	-$25M	+$16.7M	CGEM, ITOS, TCRR, RPTX, HARP	13F-HR	8/13/2021, 09:24 AM
Q1 2021	13	$796M	+$330M	-$33.7M	+$296M	CGEM, HARP, ITOS, TCRR, RPTX	13F-HR	5/13/2021, 03:46 PM
Q4 2020	13	$569M	+$76.8M	-$5.68M	+$71.2M	TCRR, RPTX, ITOS, ONCR, HARP	13F-HR/A	2/24/2021, 04:55 PM
Q4 2020	16	$589M	+$90.3M	$0	+$90.3M	TCRR, RPTX, ITOS, ONCR, HARP	13F-HR	2/16/2021, 06:45 AM
Q3 2020	12	$415M	+$64.4M	$0	+$64.4M	RPTX, TCRR, HARP, ITOS, EPZM	Restatement	11/19/2020, 02:36 PM
Q2 2020	11	$376M	+$127M	-$7.73M	+$119M	RPTX, HARP, TCRR, EPZM, GTHX	13F-HR	8/12/2020, 12:12 PM
Q1 2020	10	$164M	+$13.8M	-$46.8M	-$33M	HARP, EPZM, TCRR, GTHX, TPTX	13F-HR	5/13/2020, 12:16 PM
Q4 2019	12	$282M	$0	$0		HARP, EPZM, TCRR, GTHX, ARQL	13F-HR	2/14/2020, 03:03 PM

Previous1Next

Showing 1 to 22 of 22 entries